APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Joint Pain Injections

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Joint Pain Injections Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174005360323 December 2025190 pages

Choose your research edition.

Industry ResearchJoint Pain Injections Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Joint Pain Injections Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Joint Pain Injections Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Joint Pain Injections Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Joint Pain Injections Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Joint Pain Injections market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Joint Pain Injections is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Joint Pain Injections is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Joint Pain Injections is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Joint Pain Injections is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Joint Pain Injections include Chugai Pharmaceutical, Sanofi, Pfizer, Ferring, Zimmer Biomet Holdings, SEIKAGAKU CORPORATION, Flexion Therapeutics, Bioventus and Anika Therapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Joint Pain Injections market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Joint Pain Injections and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Joint Pain Injections sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Joint Pain Injections market size, projected growth trends, production technologies, key applications, and end-use industries.

Joint Pain Injections Segment by Company

Chugai Pharmaceutical

Sanofi

Pfizer

Ferring

Zimmer Biomet Holdings

SEIKAGAKU CORPORATION

Flexion Therapeutics

Bioventus

Anika Therapeutics

Allergan

Joint Pain Injections Segment by Type

Corticosteroid Injections

Hyaluronic Acid Injections

Others

Joint Pain Injections Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Joint Pain Injections Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Joint Pain Injections market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Joint Pain Injections and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Joint Pain Injections.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Joint Pain Injections market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Joint Pain Injections manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Joint Pain Injections in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Joint Pain Injections in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Joint Pain Injections Industry Trends Table 2. Joint Pain Injections Industry Drivers Table 3. Joint Pain Injections Industry Opportunities and Challenges Table 4. Joint Pain Injections Industry Restraints Table 5. Global Joint Pain Injections Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Joint Pain Injections Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Joint Pain Injections Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Joint Pain Injections Sales Market Share by Manufacturers Table 9. Global Joint Pain Injections Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Joint Pain Injections Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Joint Pain Injections Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Joint Pain Injections Manufacturers, Product Type & Application Table 13. Global Joint Pain Injections Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Joint Pain Injections by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Corticosteroid Injections Table 17. Major Manufacturers of Hyaluronic Acid Injections Table 18. Major Manufacturers of Others Table 19. Global Joint Pain Injections Sales by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Joint Pain Injections Sales by Type (2021-2026) & (k units) Table 21. Global Joint Pain Injections Sales by Type (2027-2032) & (k units) Table 22. Global Joint Pain Injections Sales Market Share by Type (2021-2026) Table 23. Global Joint Pain Injections Sales Market Share by Type (2027-2032) Table 24. Global Joint Pain Injections Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 25. Global Joint Pain Injections Revenue by Type (2021-2026) & (k units) Table 26. Global Joint Pain Injections Revenue by Type (2027-2032) & (k units) Table 27. Global Joint Pain Injections Revenue Market Share by Type (2021-2026) Table 28. Global Joint Pain Injections Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospital Pharmacies Table 30. Major Manufacturers of Online Pharmacies Table 31. Major Manufacturers of Retail Pharmacies Table 32. Global Joint Pain Injections Sales by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Joint Pain Injections Sales by Application (2021-2026) & (k units) Table 34. Global Joint Pain Injections Sales by Application (2027-2032) & (k units) Table 35. Global Joint Pain Injections Sales Market Share by Application (2021-2026) Table 36. Global Joint Pain Injections Sales Market Share by Application (2027-2032) Table 37. Global Joint Pain Injections Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global Joint Pain Injections Revenue by Application (2021-2026) & (k units) Table 39. Global Joint Pain Injections Revenue by Application (2027-2032) & (k units) Table 40. Global Joint Pain Injections Revenue Market Share by Application (2021-2026) Table 41. Global Joint Pain Injections Revenue Market Share by Application (2027-2032) Table 42. Global Joint Pain Injections Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Joint Pain Injections Sales by Region (2021-2026) & (k units) Table 44. Global Joint Pain Injections Sales Market Share by Region (2021-2026) Table 45. Global Joint Pain Injections Sales Forecasted by Region (2027-2032) & (k units) Table 46. Global Joint Pain Injections Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Joint Pain Injections Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 48. North America Joint Pain Injections Sales by Country (2021-2026) & (k units) Table 49. North America Joint Pain Injections Sales by Country (2027-2032) & (k units) Table 50. Europe Joint Pain Injections Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. Europe Joint Pain Injections Sales by Country (2021-2026) & (k units) Table 52. Europe Joint Pain Injections Sales by Country (2027-2032) & (k units) Table 53. Asia Pacific Joint Pain Injections Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Asia Pacific Joint Pain Injections Sales by Country (2021-2026) & (k units) Table 55. Asia Pacific Joint Pain Injections Sales by Country (2027-2032) & (k units) Table 56. South America, Middle East and Africa Joint Pain Injections Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. South America, Middle East and Africa Joint Pain Injections Sales by Country (2021-2026) & (k units) Table 58. South America, Middle East and Africa Joint Pain Injections Sales by Country (2027-2032) & (k units) Table 59. Global Joint Pain Injections Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Joint Pain Injections Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Joint Pain Injections Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Joint Pain Injections Revenue Market Share by Region (2021-2026) Table 63. Global Joint Pain Injections Revenue Market Share by Region (2027-2032) Table 64. Chugai Pharmaceutical Company Information Table 65. Chugai Pharmaceutical Business Overview Table 66. Chugai Pharmaceutical Joint Pain Injections Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Chugai Pharmaceutical Joint Pain Injections Product Portfolio Table 68. Chugai Pharmaceutical Recent Development Table 69. Sanofi Company Information Table 70. Sanofi Business Overview Table 71. Sanofi Joint Pain Injections Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Sanofi Joint Pain Injections Product Portfolio Table 73. Sanofi Recent Development Table 74. Pfizer Company Information Table 75. Pfizer Business Overview Table 76. Pfizer Joint Pain Injections Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Pfizer Joint Pain Injections Product Portfolio Table 78. Pfizer Recent Development Table 79. Ferring Company Information Table 80. Ferring Business Overview Table 81. Ferring Joint Pain Injections Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Ferring Joint Pain Injections Product Portfolio Table 83. Ferring Recent Development Table 84. Zimmer Biomet Holdings Company Information Table 85. Zimmer Biomet Holdings Business Overview Table 86. Zimmer Biomet Holdings Joint Pain Injections Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Zimmer Biomet Holdings Joint Pain Injections Product Portfolio Table 88. Zimmer Biomet Holdings Recent Development Table 89. SEIKAGAKU CORPORATION Company Information Table 90. SEIKAGAKU CORPORATION Business Overview Table 91. SEIKAGAKU CORPORATION Joint Pain Injections Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. SEIKAGAKU CORPORATION Joint Pain Injections Product Portfolio Table 93. SEIKAGAKU CORPORATION Recent Development Table 94. Flexion Therapeutics Company Information Table 95. Flexion Therapeutics Business Overview Table 96. Flexion Therapeutics Joint Pain Injections Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Flexion Therapeutics Joint Pain Injections Product Portfolio Table 98. Flexion Therapeutics Recent Development Table 99. Bioventus Company Information Table 100. Bioventus Business Overview Table 101. Bioventus Joint Pain Injections Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Bioventus Joint Pain Injections Product Portfolio Table 103. Bioventus Recent Development Table 104. Anika Therapeutics Company Information Table 105. Anika Therapeutics Business Overview Table 106. Anika Therapeutics Joint Pain Injections Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Anika Therapeutics Joint Pain Injections Product Portfolio Table 108. Anika Therapeutics Recent Development Table 109. Allergan Company Information Table 110. Allergan Business Overview Table 111. Allergan Joint Pain Injections Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Allergan Joint Pain Injections Product Portfolio Table 113. Allergan Recent Development Table 114. Key Raw Materials Table 115. Raw Materials Key Suppliers Table 116. Joint Pain Injections Distributors List Table 117. Joint Pain Injections Customers List Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Joint Pain Injections Product Image Figure 2. Global Joint Pain Injections Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Joint Pain Injections Market Size (2021-2032) & (US$ Million) Figure 4. Global Joint Pain Injections Sales (2021-2032) & (k units) Figure 5. Global Joint Pain Injections Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Joint Pain Injections Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Corticosteroid Injections Image Figure 9. Hyaluronic Acid Injections Image Figure 10. Others Image Figure 11. Global Joint Pain Injections Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Joint Pain Injections Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Joint Pain Injections Sales Market Share by Type (2021-2032) Figure 14. Global Joint Pain Injections Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Joint Pain Injections Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Joint Pain Injections Revenue Market Share by Type (2021-2032) Figure 17. Hospital Pharmacies Image Figure 18. Online Pharmacies Image Figure 19. Retail Pharmacies Image Figure 20. Global Joint Pain Injections Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Joint Pain Injections Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Joint Pain Injections Sales Market Share by Application (2021-2032) Figure 23. Global Joint Pain Injections Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Joint Pain Injections Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Joint Pain Injections Revenue Market Share by Application (2021-2032) Figure 26. North America Joint Pain Injections Sales and Growth Rate (2021-2032) & (k units) Figure 27. North America Joint Pain Injections Sales Market Share by Country (2021-2032) Figure 28. U.S. Joint Pain Injections Sales and Growth Rate (2021-2032) & (k units) Figure 29. Canada Joint Pain Injections Sales and Growth Rate (2021-2032) & (k units) Figure 30. Mexico Joint Pain Injections Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Joint Pain Injections Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Joint Pain Injections Sales Market Share by Country (2021-2032) Figure 33. Germany Joint Pain Injections Sales and Growth Rate (2021-2032) & (k units) Figure 34. France Joint Pain Injections Sales and Growth Rate (2021-2032) & (k units) Figure 35. U.K. Joint Pain Injections Sales and Growth Rate (2021-2032) & (k units) Figure 36. Italy Joint Pain Injections Sales and Growth Rate (2021-2032) & (k units) Figure 37. Netherlands Joint Pain Injections Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Joint Pain Injections Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Joint Pain Injections Sales Market Share by Country (2021-2032) Figure 40. China Joint Pain Injections Sales and Growth Rate (2021-2032) & (k units) Figure 41. Japan Joint Pain Injections Sales and Growth Rate (2021-2032) & (k units) Figure 42. South Korea Joint Pain Injections Sales and Growth Rate (2021-2032) & (k units) Figure 43. Southeast Asia Joint Pain Injections Sales and Growth Rate (2021-2032) & (k units) Figure 44. India Joint Pain Injections Sales and Growth Rate (2021-2032) & (k units) Figure 45. Australia Joint Pain Injections Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Joint Pain Injections Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Joint Pain Injections Sales Market Share by Country (2021-2032) Figure 48. Brazil Joint Pain Injections Sales and Growth Rate (2021-2032) & (k units) Figure 49. South Africa Joint Pain Injections Sales and Growth Rate (2021-2032) & (k units) Figure 50. Saudi Arabia Joint Pain Injections Sales and Growth Rate (2021-2032) & (k units) Figure 51. Turkey Joint Pain Injections Sales and Growth Rate (2021-2032) & (k units) Figure 52. Argentina Joint Pain Injections Sales and Growth Rate (2021-2032) & (k units) Figure 53. UAE Joint Pain Injections Sales and Growth Rate (2021-2032) & (k units) Figure 54. Egypt Joint Pain Injections Sales and Growth Rate (2021-2032) & (k units) Figure 55. Chile Joint Pain Injections Sales and Growth Rate (2021-2032) & (k units) Figure 56. Global Joint Pain Injections Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Joint Pain Injections Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Joint Pain Injections Revenue (2021-2032) & (US$ Million) Figure 59. North America Joint Pain Injections Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Joint Pain Injections Revenue (2021-2032) & (US$ Million) Figure 61. Europe Joint Pain Injections Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Joint Pain Injections Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Joint Pain Injections Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Joint Pain Injections Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Joint Pain Injections Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Joint Pain Injections Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Joint Pain Injections Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Corticosteroid Injections
  • Hyaluronic Acid Injections
  • Others
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Chugai Pharmaceutical
  • Sanofi
  • Pfizer
  • Ferring
  • Zimmer Biomet Holdings
  • SEIKAGAKU CORPORATION
  • Flexion Therapeutics
  • Bioventus
  • Anika Therapeutics
  • Allergan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Joint Pain Injections Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Joint Pain Injections Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Joint Pain Injections Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Joint Pain Injections Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Joint Pain Injections Market Dynamics
  1. 2.1 Joint Pain Injections Industry Trends
  2. 2.2 Joint Pain Injections Industry Drivers
  3. 2.3 Joint Pain Injections Industry Opportunities and Challenges
  4. 2.4 Joint Pain Injections Industry Restraints
3 Joint Pain Injections Market by Manufacturers
  1. 3.1 Global Joint Pain Injections Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Joint Pain Injections Sales by Manufacturers (2021-2026)
  3. 3.3 Global Joint Pain Injections Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Joint Pain Injections Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Joint Pain Injections Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Joint Pain Injections Manufacturers, Product Type & Application
  7. 3.7 Global Joint Pain Injections Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Joint Pain Injections Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Joint Pain Injections Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Joint Pain Injections Tier 1, Tier 2, and Tier 3
4 Joint Pain Injections Market by Type
  1. 4.1 Joint Pain Injections Type Introduction
  2. 4.1.1 Corticosteroid Injections
  3. 4.1.2 Hyaluronic Acid Injections
  4. 4.1.3 Others
  5. 4.2 Global Joint Pain Injections Sales by Type
  6. 4.2.1 Global Joint Pain Injections Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Joint Pain Injections Sales by Type (2021-2032)
  8. 4.2.3 Global Joint Pain Injections Sales Market Share by Type (2021-2032)
  9. 4.3 Global Joint Pain Injections Revenue by Type
  10. 4.3.1 Global Joint Pain Injections Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Joint Pain Injections Revenue by Type (2021-2032)
  12. 4.3.3 Global Joint Pain Injections Revenue Market Share by Type (2021-2032)
5 Joint Pain Injections Market by Application
  1. 5.1 Joint Pain Injections Application Introduction
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Retail Pharmacies
  5. 5.2 Global Joint Pain Injections Sales by Application
  6. 5.2.1 Global Joint Pain Injections Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Joint Pain Injections Sales by Application (2021-2032)
  8. 5.2.3 Global Joint Pain Injections Sales Market Share by Application (2021-2032)
  9. 5.3 Global Joint Pain Injections Revenue by Application
  10. 5.3.1 Global Joint Pain Injections Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Joint Pain Injections Revenue by Application (2021-2032)
  12. 5.3.3 Global Joint Pain Injections Revenue Market Share by Application (2021-2032)
6 Global Joint Pain Injections Sales by Region
  1. 6.1 Global Joint Pain Injections Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Joint Pain Injections Sales by Region (2021-2032)
  3. 6.2.1 Global Joint Pain Injections Sales by Region (2021-2026)
  4. 6.2.2 Global Joint Pain Injections Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Joint Pain Injections Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Joint Pain Injections Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Joint Pain Injections Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Joint Pain Injections Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Joint Pain Injections Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Joint Pain Injections Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Joint Pain Injections Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Joint Pain Injections Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Joint Pain Injections Revenue by Region
  1. 7.1 Global Joint Pain Injections Revenue by Region
  2. 7.1.1 Global Joint Pain Injections Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Joint Pain Injections Revenue by Region (2021-2026)
  4. 7.1.3 Global Joint Pain Injections Revenue by Region (2027-2032)
  5. 7.1.4 Global Joint Pain Injections Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Joint Pain Injections Revenue (2021-2032)
  8. 7.2.2 North America Joint Pain Injections Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Joint Pain Injections Revenue (2021-2032)
  11. 7.3.2 Europe Joint Pain Injections Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Joint Pain Injections Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Joint Pain Injections Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Joint Pain Injections Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Joint Pain Injections Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Chugai Pharmaceutical
  2. 8.1.1 Chugai Pharmaceutical Company Information
  3. 8.1.2 Chugai Pharmaceutical Business Overview
  4. 8.1.3 Chugai Pharmaceutical Joint Pain Injections Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Chugai Pharmaceutical Joint Pain Injections Product Portfolio
  6. 8.1.5 Chugai Pharmaceutical Recent Developments
  7. 8.2 Sanofi
  8. 8.2.1 Sanofi Company Information
  9. 8.2.2 Sanofi Business Overview
  10. 8.2.3 Sanofi Joint Pain Injections Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Joint Pain Injections Product Portfolio
  12. 8.2.5 Sanofi Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer Joint Pain Injections Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Joint Pain Injections Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 Ferring
  20. 8.4.1 Ferring Company Information
  21. 8.4.2 Ferring Business Overview
  22. 8.4.3 Ferring Joint Pain Injections Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Ferring Joint Pain Injections Product Portfolio
  24. 8.4.5 Ferring Recent Developments
  25. 8.5 Zimmer Biomet Holdings
  26. 8.5.1 Zimmer Biomet Holdings Company Information
  27. 8.5.2 Zimmer Biomet Holdings Business Overview
  28. 8.5.3 Zimmer Biomet Holdings Joint Pain Injections Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Zimmer Biomet Holdings Joint Pain Injections Product Portfolio
  30. 8.5.5 Zimmer Biomet Holdings Recent Developments
  31. 8.6 SEIKAGAKU CORPORATION
  32. 8.6.1 SEIKAGAKU CORPORATION Company Information
  33. 8.6.2 SEIKAGAKU CORPORATION Business Overview
  34. 8.6.3 SEIKAGAKU CORPORATION Joint Pain Injections Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 SEIKAGAKU CORPORATION Joint Pain Injections Product Portfolio
  36. 8.6.5 SEIKAGAKU CORPORATION Recent Developments
  37. 8.7 Flexion Therapeutics
  38. 8.7.1 Flexion Therapeutics Company Information
  39. 8.7.2 Flexion Therapeutics Business Overview
  40. 8.7.3 Flexion Therapeutics Joint Pain Injections Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Flexion Therapeutics Joint Pain Injections Product Portfolio
  42. 8.7.5 Flexion Therapeutics Recent Developments
  43. 8.8 Bioventus
  44. 8.8.1 Bioventus Company Information
  45. 8.8.2 Bioventus Business Overview
  46. 8.8.3 Bioventus Joint Pain Injections Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Bioventus Joint Pain Injections Product Portfolio
  48. 8.8.5 Bioventus Recent Developments
  49. 8.9 Anika Therapeutics
  50. 8.9.1 Anika Therapeutics Company Information
  51. 8.9.2 Anika Therapeutics Business Overview
  52. 8.9.3 Anika Therapeutics Joint Pain Injections Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Anika Therapeutics Joint Pain Injections Product Portfolio
  54. 8.9.5 Anika Therapeutics Recent Developments
  55. 8.10 Allergan
  56. 8.10.1 Allergan Company Information
  57. 8.10.2 Allergan Business Overview
  58. 8.10.3 Allergan Joint Pain Injections Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Allergan Joint Pain Injections Product Portfolio
  60. 8.10.5 Allergan Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Joint Pain Injections Value Chain Analysis
  2. 9.1.1 Joint Pain Injections Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Joint Pain Injections Production Mode & Process
  6. 9.2 Joint Pain Injections Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Joint Pain Injections Distributors
  9. 9.2.3 Joint Pain Injections Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst